title: Sorafenib-associated psoriasiform eruption in a patient with hepatocellular carcinoma.
authors.forename: Turna
authors.initials: T
authors.lastname: İlknur
authors.forename: Sevgi
authors.initials: S
authors.lastname: Akarsu
authors.forename: Saim
authors.initials: S
authors.lastname: Çarsanbali
authors.forename: Banu
authors.initials: B
authors.lastname: Lebe
authors.forename: Emel
authors.initials: E
authors.lastname: Fetil
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000473:pathology; D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D009362:Neoplasm Metastasis; D009536:Niacinamide / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D010671:Phenylurea Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib